Loading...
Loading...
CDC PLACES (2023, crude) estimates 6.1% of adults in Seattle have diagnosed diabetes — 5.9 points below the U.S. 12% figure. Census population 749,256. Washington Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Seattle clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Seattle storefront.
Pressure Ulcer Treatment Solutions in Seattle, WA for clinics & physicians. Advanced pressure ulcer treatm… Compliance support & pricing — contact Hawk Medical.
6.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 6.1% of adults in Seattle have diagnosed diabetes — 5.9 points below the U.S. 12% figure. Population 749,256. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JF documentation are ready before the first application of pressure ulcer treatment.
National Pressure Ulcer Treatment Solutions notes (how the product actually works)6.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 500k–1M with 749,256 residents will still mix those payers. CDC PLACES (2023, crude) estimates 6.1% of adults in Seattle have diagnosed diabetes — 5.9 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 6.1% of adults in Seattle have diagnosed diabetes — 5.9 points below the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the pressure ulcer treatment account.
CDC PLACES (2023, crude prevalence) estimates 6.1% of adults — 5.9 points below the U.S. 12% figure. Obesity is 22.2%; arthritis is 17%. That is place-level BRFSS modeling, not a clinic census and not a Seattle trial.
This URL is written for healthcare providers shopping distribution. Patient-facing ads must follow your state medical board and FTC rules. Do not copy distributor language into consumer ads that imply guaranteed healing.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Washington.
No. They are B2B distribution pages for licensed providers. Patients in Seattle should speak with their clinician, not use a distributor URL as care instructions.
Bring specialty, monthly wound volume, and whether you bill JF FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 6.1% diabetes and 17% arthritis for Seattle — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Seattle, WA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Seattle is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Seattle — 5.9 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Washington Part B wound biologics follow this contractor (siblings: AK, AZ, ID, MT, ND, OR, SD, UT, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Seattle. Useful for joint-program math; still needs a diagnosis and privileging.
No Seattle storefront. Joe Bradley is an active practice owner. pressure ulcer treatment stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.